According to our new research study on “ELISA Diagnostic Test Market Size and Forecast to 2030 – Global and Regional Analysis – by Adoption, Test Type, Application, End User, and Geography,” the market is expected to grow from US$ 1,285.49 million in 2022 to US$ 2,271.23 million by 2030; it is estimated to register a CAGR of 7.37% from 2022 to 2030. Rising incidence of infectious diseases among animals and increasing incidence of infections among humans drive the market growth. However, incidents of product recalls hamper the market growth.
The Enzyme-Linked Immunosorbent Assay (ELISA) technique is used to detect infectious agents or antibodies in a sample. Antibodies are produced by the body as a response to infection. Therefore, the ELISA test can determine if an animal has come into contact with a specific virus. On the other hand, an antigen ELISA can directly identify whether an animal is carrying a virus. ELISA kits are a valuable research tool that offer quick, convenient, and precise detection and quantitation of specific targets in samples and cultures. Commercially available ELISA kits come with pre-coated plates, capture/detection antibodies, standards, buffers, and other necessary reagents. Each kit undergoes rigorous validation and stability testing to ensure accuracy, precision, sensitivity, specificity, and reproducibility.
ELISA Diagnostic Test Market, by Geography, 2022 (%)
ELISA Diagnostics Tests Market Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography
ELISA Diagnostic Test Market Research Report 2020-2030
Download Free Sample
Source: The Insight Partners Analysis
The ELISA diagnostic test market is segmented on the basis of adoption, test type, application, and end user. In terms of adoption, the market is bifurcated into human and veterinary. The human segment held a larger market share in 2022 and is anticipated to register a higher CAGR of 7.88% during the forecast period. Infectious diseases are caused by infectious agents such as fungi, viruses, bacteria, parasites, and other pathogens. With the growing environmental changes and poor sanitation conditions, infection cases are rising in humans, and new diseases are emerging worldwide. Serological tests such as ELISA can detect viral and bacterial antigens and antibodies to help diagnose these diseases in their early stage in biological samples such as blood, urine, plasma, and stool samples. Therefore, the rising incidence of these infectious diseases among the population is boosting the global ELISA diagnostic test market growth for the humans segment.
- Based on test type, the global ELISA diagnostic test market is segmented into sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA.
- By application, the global ELISA diagnostic test market is segmented into immunology, infectious diseases, cancer diagnosis, protein quantification, and others.
- Based on end user, the market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, veterinary diagnostic laboratories, and others.
Innovative Product Launches to Create Opportunities for ELISA Diagnostic Test Market Growth During Forecast Period
ELISA is one of the most popular immunoassay tests owing to its various advantages such as flexibility, sensitivity, and easy-to-use features. Also, low cost of ELISA test kit and multifaceted applicability associated with high-throughput testing make it an ideal solution for various research and IVD requirements. With low-cost applicability, product innovations in the test kits enhance the demand for human and animal research. Also, manufacturers focus on developing ELISA test kits with in-house facilities.
Innovative Research company sells a wide range of ELISA kits with selectivity to a broad range in identifying coagulants, species, and antibodies. "Human Factor IX Kit" is one such example manufactured by Innovative Research. The human coagulation Factor IX antigen assay is intended for the quantitative determination of total Factor IX antigen in human plasma. The kit is recommended to use only for research purposes, and reagents can be utilized for up to 96 clinical tests.
Additionally, innovative product launches for ELISA tests by the manufacturers amid the COVID-19 pandemic accelerate the adoption of ELISA testing among humans.
ELISA Diagnostic Test Market: Competitive Landscape and Key Developments
Bio-Rad Laboratories Inc., Idexx Laboratories Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corp, Innovative Diagnostics SAS, Pictor Ltd, DiaSorin SpA, Elabscience Biotechnology Inc, and Bio-Techne Corp are among the major players in the ELISA Diagnostic Test market. These leading players adopt strategies such as the launch of new products, expansion and diversification of their market presence, and expansion of new customer base to tap prevailing business opportunities.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com